Technological innovation projects of small and medium-sized scientific and technological enterprises are divided into two categories: innovative projects and key innovative projects. The specific requirements are as follows:
Innovative projects
1. Free-funded innovative projects
Necessary subsidies for technological innovation products in the research, development and pilot stage. The reporting enterprise shall meet the following conditions:
(1) The registered paid-in capital is not less than RMB 300,000;
(2) The number of employees shall not exceed 300;
(3) Its total assets are not higher than 50 million yuan;
(4) The annual business income does not exceed 50 million yuan;
(5) The declared project has not yet formed a sales scale;
(6) The planned new investment of the project is below100,000 yuan, the source of funds is determined, and the investment structure is reasonable. In the new investment project plan, the enterprise must have its own funds that match the declared local funds and innovation funds; Under normal circumstances, the amount of subsidy declared by an enterprise should not be greater than the net assets of the enterprise.
The implementation period of the project is two years, and the technical and economic indicators that the project plans to achieve should be calculated according to the full two years (the implementation period is calculated from the date of project declaration); The implementation period of the new drug project can be appropriately extended to three years. When the drug project is completed, there may be no economic indicators such as operating income, but there must be clear and assessable targets, such as acceptance notice, clinical approval, new drug certificate, etc. For details, please refer to the relevant requirements in the biological and pharmaceutical fields in the project guide.
As can be seen from the above, if there is no fixed subsidy declared by the enterprise, then the subsidy amount of each enterprise is different, but the premise is that it should not be greater than the net assets of the enterprise.